Clinical Trial

Evaluating Intact Fish Skin Graft and Standard of Care Versus Standard of Care Alone in Nonhealing Venous Leg Ulcers

Study acronym: THOR
Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated January 24, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to determine the between-arm difference in the proportion of subjects achieving complete closure of hard-to-heal venous leg ulcers (VLU) between Intact Fish Skin Graft plus standard of care (IFSG/SOC) versus standard of care alone (SOC) over 12 weeks.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-11-15; most recent amendment 2025-01-22.
Status change: Not Yet Recruiting → Recruiting 2024-11-19
Trial Details
NCT Number NCT06693570
Lead Sponsor Kerecis Ltd.
Collaborators: Serena Group
Conditions Venous Leg Ulcer (VLU), Venous Leg Ulcers, Venous Leg, Nonhealing Venous Leg Ulcer
Enrollment 150 participants
Start Date 2024-11-25
Primary Completion 2026-04 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2025-01-24